Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. Aug. 15, 2018. Kevin Brown.

Executive Summary

Kevin Brown, physicist and global VP of scientific research for device-maker Elekta, says his company has rejected some product ideas because they ultimately wouldn't be profitable. See what he said here.

"I don't think it is possible to separate the commercial and the clinical, in reality. If the idea doesn't have a clinical value, it won't really be a commercial success. If a product brings a lot of value to the patient, then the clinician will value it, and it will be prioritized in terms of their implementation. On occasion, there are those ideas that are likely to have clinical value, but may not be accepted that well. When the idea of CBCT [cone beam-computed tomography] integration was first proposed, there were quite a few people who were cynical about it being successful. They thought it was too expensive, too complicated, and it wasn't until we started to demonstrate to the clinicians what the technology could provide that they started to see it could have some value to them in terms of the way they treated their patients. There was a period of skepticism that we have to go through." –Kevin Brown, physicist and global VP of scientific research, Elekta AB

Click here for a free trial of Medtech Insight

 
Advertisement

Related Content

Hindsight 20/20: Elekta's Kevin Brown

Topics

Advertisement
UsernamePublicRestriction

Register

MT123132

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel